Prognostic Value of Somatostatin Receptor Scintigraphy on High-Grade Neuroendocrine Neoplasms and Impact on the Treatment Decision of Intermediate-Grade Neuroendocrine Neoplasms

#978

Introduction: Somatostatin receptor scintigraphy (SRS) could detect not only somatostatin receptors but also tumor images in patients with neuroendocrine neoplasms (NENs).

Aim(s): To evaluate the clinical utility of SRS in the prognosis and management of patients with NENs.

Materials and methods: We retrospectively analyzed 49 pts with non-resectable and pathologically confirmed NENs who underwent SRS.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Jia R

Authors: Jia R, Fu Y, Lin L, Wang Y, Ge F,

Keywords: neuroendocrine, SRS, prognosis,